Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shenyang Neusoft Zhirui Radiotherapy Technology

Request full access

Precision oncology equipment for intelligent radiotherapy treatment

ChinaFounded 2018

About Shenyang Neusoft Zhirui Radiotherapy Technology

Shenyang Neusoft Zhirui Radiotherapy Technology, also known as IntelliRay, develops and researches oncology treatment equipment. The company was founded in 2018 and is headquartered in Shenyang, China. IntelliRay is a subsidiary of Neusoft Medical Systems, which in turn is a subsidiary of Neusoft Corporation, China's largest IT solutions and services provider. The parent company, Neusoft, was founded in 1991 by professors from Northeastern University and was the first listed software company in China.

The company focuses on creating accurate and intelligent radiotherapy technologies to improve the effectiveness of cancer treatments. Its product line includes the NeuRT Aurora, a device that provides diagnostic-grade image-guided precise irradiation, and NeuOIS, a cloud-based remote radiation therapy platform. IntelliRay's solutions are part of a broader portfolio from Neusoft Medical that includes CT scanners, MRI systems, linear accelerators, and treatment planning software. The technology incorporates features like the Collapsed Cone Convolution Superposition (CCCS) algorithm, considered a highly accurate 3D dose calculation model, and powerful 3D visualization tools.

IntelliRay operates as a venture capital-backed, privately held company. It has successfully raised capital through multiple funding rounds, including a Series C round in June 2024 that raised CNY 100 million, led by Neusoft and Lucky Capital. Other notable investors include In Capital, Lenovo Capital and Incubator Group, 6 Dimensions Capital, and Ivy Capital.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
12.0/100
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Jun 2024 $14M $55M Neusoft · Lucky Capital ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Shenyang Neusoft Zhirui Radiotherapy Technology website traffic

Latest recorded traffic for Shenyang Neusoft Zhirui Radiotherapy Technology is 110 monthly website visits, down 73.8% over the last three months.

Latest monthly visits110 3-month web change-73.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shenyang Neusoft Zhirui Radiotherapy Technology in its local ecosystem

Live from Dealroom

The Shenyang Neusoft Zhirui Radiotherapy Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Neusoft
  • Lucky Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shenyang Neusoft Zhirui Radiotherapy Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shenyang Neusoft Zhirui Radiotherapy Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.